Oct 4 |
Relief gains as experimental therapy performs on par with BioMarin’s Kuvan
|
Oct 4 |
Do Options Traders Know Something About BioMarin (BMRN) Stock We Don't?
|
Oct 1 |
3 Reasons Why Growth Investors Shouldn't Overlook BioMarin (BMRN)
|
Oct 1 |
BMRN or MYGN: Which Is the Better Value Stock Right Now?
|
Oct 1 |
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
|
Oct 1 |
Down -22.94% in 4 Weeks, Here's Why You Should You Buy the Dip in BioMarin (BMRN)
|
Sep 30 |
Andreas Halvorsen's Strategic Acquisition in BioMarin Pharmaceutical Inc
|
Sep 30 |
Andreas Halvorsen's Firm Expands Grip in BioMarin Pharmaceutical Inc Holding
|
Sep 30 |
High Growth Tech Stocks To Watch For Future Potential
|
Sep 25 |
BioMarin Stands Firm on 2027 Revenue Target Amid Ascendis Competition, Goldman Sachs Analyst Remains Bullish
|